12th Annual Guide to Retinal Disease

What have we learned from a decade of study and clinical use? Our experts review.

  • Neovascularization: What is it and What Does it Mean?
    By Mariem Abdou, OD, and Joseph W. Sowka, OD
  • Clinical Manifestations of VEGF-Mediated Retinal Disease
    By Julie Rodman, OD, MS, and Sherrol A. Reynolds, OD
  • Stemming the Tide: How Anti-VEGF Therapies Confront Neovascularization
    By Christopher L. Suhr, OD
  • The Optometrist’s Role in Anti-VEGF Therapy
    By Julie Torbit, OD and Brad Sutton, OD